Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.3.901

MLH1 Polymorphisms and Cancer risk: a Meta-analysis Based on 33 Case-control Studies  

Xu, Jia-Li (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Yin, Zhi-Qiang (Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University)
Huang, Ming-De (Department of Oncology, Huai'an No. 1 hospital affiliated to Nanjing Medical University)
Wang, Xie-Feng (Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University)
Gao, Wen (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Liu, Ling-Xiang (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Wang, Rong-Sheng (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Huang, Pu-Wen (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Yin, Yong-Mei (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Liu, Ping (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Shu, Yong-Qian (Department of Oncology, The First Affiliated Hospital of Nanjing Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.3, 2012 , pp. 901-907 More about this Journal
Abstract
Objective: Cumulative evidence suggests that MLH1, the key component in the mismatch pathway, plays an important role in human cancers. Two potential functional polymorphisms (-93G>A and I219V) of MLH1 have been implicated in cancer risk. The aim of this meta-analysis was to summarize the evidence for associations. Methods: Eligible studies were identified by searching the electronic literature PubMed, ScienceDirect and Embase databases for relevant reports and bibliographies. Studies were included if of case-control design investigating MLH1 polymorphisms (-93G>A and I219V) and cancer risk with sufficient raw data for analysis. Odds ratios (OR) and 95% confidence intervals (95% CI) were used to evaluate the strength of associations. Results: Our meta-analysis from 33 published case-control studies showed the variant A allele of -93G>A polymorphism to be associated with increased risk in all genetic models (AA vs. GG: OR = 1.22, 95% CI: 1.03-1.44), especially among non-Asians (AA vs. GG: OR = 1.28, 95% CI: 1.04-1.58). For the I219V polymorphism, however, there was no main effect associated with overall cancer risk in any genetic model. Conclusions: The meta-analysis suggested that the MLH1 -93G>A polymorphism may be a biomarker of cancer susceptibility. Large sample association studies and assessment of gene-to-gene as well as gene-to-environment interactions are required to confirm these findings.
Keywords
MLH1; cancer; polymorphism; meta-analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Song H, Ramus SJ, Quaye L, et al (2006). Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis, 27, 2235-42.   DOI
2 Song L, Zhang XM, Wang DQ, et al (2010). Mismatch repair gene hMLH1 A655G/A polymorphism and colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 13, 216-8.
3 Surtees JA, Argueso JL, Alani E (2004). Mismatch repair proteins: key regulators of genetic recombination. Cytogenet Genome Res, 107, 146-59.   DOI
4 Tanaka Y, Zaman MS, Majid S, et al (2009). Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer. Biochem Biophys Res Commun, 383, 440-4.   DOI
5 Tulupova E, Kumar R, Hanova M, et al (2008). Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer? Mutat Res, 648, 40-5.   DOI
6 van Roon EH, van Puijenbroek M, Middeldorp A, et al (2010). Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? BMC Cancer, 10, 180.   DOI
7 Wang Y, Cortez D, Yazdi P, et al (2000). BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev, 14, 927-39.
8 Whiffin N, Broderick P, Lubbe SJ, et al (2011). MLH1-93G > A is a risk factor for MSI colorectal cancer. Carcinogenesis, Epub ahead of print.
9 Xinarianos G, Liloglou T, Prime W, et al (2000). hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res, 60, 4216-21.
10 Zienolddiny S, Ryberg D, Gazdar AF, Haugen A (1999). DNA mismatch binding in human lung tumor cell lines. Lung Cancer, 26, 15-25.   DOI
11 Allan JM, Shorto J, Adlard J, et al (2008). MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int J Cancer, 123, 2456-9.   DOI
12 An Y, Jin G, Wang H, et al (2008). Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population. Lung Cancer, 59, 164-70.   DOI
13 Barnes DE (2002). DNA damage: air-breaks? Curr Biol, 12, R262-4.   DOI
14 Beiner ME, Rosen B, Fyles A, et al (2006). Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2. Cancer Epidemiol Biomarkers Prev, 15, 1636-40.   DOI
15 Berndt SI, Platz EA, Fallin MD, et al (2007). Mismatch repair polymorphisms and the risk of colorectal cancer. Int J Cancer, 120, 1548-54.   DOI
16 Bernstein C, Bernstein H, Payne CM, Garewal H (2002). DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res, 511, 145-78.   DOI   ScienceOn
17 Burmester JK, Suarez BK, Lin JH, et al (2004). Analysis of candidate genes for prostate cancer. Hum Hered, 57, 172-8.   DOI
18 Campbell PT, Curtin K, Ulrich CM, et al (2009). Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut, 58, 661-7.   DOI
19 Capella G, Pera G, Sala N, et al (2008). DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol, 37, 1316-25.   DOI
20 Chen CC, Yang SY, Liu CJ, et al (2005). Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol, 34, 1310-8.   DOI   ScienceOn
21 Chen H, Taylor NP, Sotamaa KM, et al (2007). Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer, 120, 1684-8.   DOI
22 Conde J, Silva SN, Azevedo AP, et al (2009). Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study. BMC Cancer, 9, 344.
23 Deng DJ, Zhou J, Zhu BD, et al (2003). Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol, 9, 26-9.   DOI
24 Deng G, Chen A, Pong E, Kim YS (2001). Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Oncogene, 20, 7120-7.   DOI
25 Duckett DR, Bronstein SM, Taya Y, Modrich P (1999). hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage. Proc Natl Acad Sci USA, 96, 12384-8.   DOI
26 Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI
27 Ellison AR, Lofing J, Bitter GA (2004). Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain. Nucleic Acids Res, 32, 5321-38.   DOI
28 Goodfellow PJ, Buttin BM, Herzog TJ, et al (2003). Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci USA, 100, 5908-13.   DOI
29 Harfe BD, Jinks-Robertson S (2000). DNA mismatch repair and genetic instability. Annu Rev Genet, 34, 359-99.   DOI
30 Harley I, Rosen B, Risch HA, et al (2008). Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1. Gynecol Oncol, 109, 384-7.   DOI
31 Hibi K, Takahashi T, Yamakawa K, et al (1992). Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7, 445-9.
32 Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002). A comprehensive review of genetic association studies. Genet Med, 4, 45-61.   DOI
33 Hsu HS, Wen CK, Tang YA, et al (2005). Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSM2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Clinical Cancer Research, 11, 5410-6.   DOI
34 Hutter P, Couturier A, Rey-Berthod C (2000). Two common forms of the human MLH1 gene may be associated with functional differences. J Med Genet, 37, 776-81.   DOI
35 Hutter P, Wijnen J, Rey-Berthod C, et al (2002). An MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1. J Med Genet, 39, 323-7.   DOI
36 Ito E, Yanagisawa Y, Iwahashi Y, et al (1999). A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun, 256, 488-94.   DOI
37 Jacob S, Praz F (2002). DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie, 84, 27-47.   DOI
38 Joshi AD, Corral R, Siegmund KD, et al (2009). Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis, 30, 472-9.   DOI   ScienceOn
39 Kim JC, Roh SA, Koo KH, et al (2004). Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam Cancer, 3, 129-37.
40 Koessler T, Oestergaard MZ, Song H, et al (2008). Common variants in mismatch repair genes and risk of colorectal cancer. Gut, 57, 1097-101.   DOI
41 Kondo E, Suzuki H, Horii A, Fukushige S (2003). A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. Cancer Res, 63, 3302-8.
42 Lacey JV, Jr., Yang H, Gaudet MM, et al (2011). Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol, 120, 167-73.   DOI
43 Landi S, Gemignani F, Canzian F, et al (2006). DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res, 66, 11062-9.   DOI
44 Langeberg WJ, Kwon EM, Koopmeiners JS, et al (2010). Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes. Cancer Epidemiol Biomarkers Prev, 19, 258-64.   DOI
45 Lau J, Antman EM, Jimenez-Silva J, et al (1992). Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med, 327, 248-54.   DOI
46 Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6.   DOI   ScienceOn
47 Lee KM, Choi JY, Kang C, et al (2005). Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clinic Cancer Res, 11, 4620-6.   DOI   ScienceOn
48 Listgarten J, Damaraju S, Poulin B, et al (2004). Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clinic Cancer Res, 10, 2725-37.   DOI
49 Lo YL, Hsiao CF, Jou YS, et al (2011). Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers. Lung Cancer, 72, 280-6.   DOI
50 Luo Y, Lin FT, Lin WC (2004). ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage. Mol Cell Biol, 24, 6430-44.   DOI
51 Mathonnet G, Krajinovic M, Labuda D, Sinnett D (2003). Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia. Br J Haematol, 123, 45-8.   DOI
52 Mei Q, Yan HL, Ding FX, et al (2006). Single-nucleotide polymorphisms of mismatch repair genes in healthy Chinese individuals and sporadic colorectal cancer patients. Cancer Genet Cytogenet, 171, 17-23.   DOI
53 Mrkonjic M, Roslin NM, Greenwood CM, et al (2010). Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer. PLoS One, 5, e13314.   DOI   ScienceOn
54 Nejda N, Iglesias D, Moreno Azcoita M, et al (2009). A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer. Cancer Genet Cytogenet, 193, 71-7.   DOI
55 Park SH, Lee GY, Jeon HS, et al (2004). -93G-->A polymorphism of hMLH1 and risk of primary lung cancer. International Journal of Cancer, 112, 678-82.   DOI   ScienceOn
56 Perera S, Mrkonjic M, Rawson JB, Bapat B (2011). Functional effects of the MLH1-93G>A polymorphism on MLH1/ EPM2AIP1 promoter activity. Oncol Rep, 25, 809-15.
57 Picelli A, Camin M, Tinazzi M, et al (2010). Three-dimensional motion analysis of the effects of auditory cueing on gait pattern in patients with Parkinson's disease: a preliminary investigation. Neurol Sci, 31, 423-30.   DOI
58 Picelli S, Zajac P, Zhou XL, et al (2010). Common variants in human CRC genes as low-risk alleles. Eur J Cancer, 46, 1041-8.   DOI   ScienceOn
59 Raevaara TE, Korhonen MK, Lohi H, et al (2005). Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology, 129, 537-49.
60 Raptis S, Mrkonjic M, Green RC, et al (2007). MLH1 -93G>A promoter polymorphism and the risk of microsatelliteunstable colorectal cancer. J Natl Cancer Inst, 99, 463-74.   DOI
61 Samowitz WS, Curtin K, Wolff RK, et al (2008). The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer, 47, 835-44.   DOI
62 Schafmayer C, Buch S, Egberts JH, et al (2007). Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer, 121, 555-8.   DOI
63 Scott K, Adamson PJ, Willett EV, et al (2008). Genetic variation in genes expressed in the germinal center and risk of B cell lymphoma among Caucasians. Haematologica, 93, 1597-600.   DOI
64 Shi WP, Bian JC, Jiang F, et al (2010). Study on genetic polymorphism of human mismatch repair gene hMLH1 and susceptibility of papillary thyroid carcinoma in Chinese Han people. Zhonghua Yu Fang Yi Xue Za Zhi, 44, 235-41.
65 Shih CM, Chen CY, Lee IH, et al (2010). A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis. Int J Mol Med, 25, 165-70.
66 Smith TR, Levine EA, Freimanis RI, et al (2008). Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis, 29, 2132-8.   DOI